These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. González-García M; Pérez-Ballestero R; Ding L; Duan L; Boise LH; Thompson CB; Núñez G Development; 1994 Oct; 120(10):3033-42. PubMed ID: 7607090 [TBL] [Abstract][Full Text] [Related]
27. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes. Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538 [TBL] [Abstract][Full Text] [Related]
29. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice. de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417 [TBL] [Abstract][Full Text] [Related]
30. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs. Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414 [TBL] [Abstract][Full Text] [Related]
31. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma. Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778 [TBL] [Abstract][Full Text] [Related]
32. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins. Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472 [TBL] [Abstract][Full Text] [Related]
33. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development. Yan Y; Park SS; Janz S; Eckhardt LA Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584 [TBL] [Abstract][Full Text] [Related]
34. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Yu D; Thomas-Tikhonenko A Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625 [TBL] [Abstract][Full Text] [Related]
35. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Schwarze MM; Hawley RG Cancer Res; 1995 Jun; 55(11):2262-5. PubMed ID: 7757973 [TBL] [Abstract][Full Text] [Related]
36. IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2. Tumang JR; Hsia CY; Tian W; Bromberg JF; Liou HC Cell Immunol; 2002; 217(1-2):47-57. PubMed ID: 12426000 [TBL] [Abstract][Full Text] [Related]
37. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene. Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300 [TBL] [Abstract][Full Text] [Related]
38. BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members. Hogg SJ; Newbold A; Vervoort SJ; Cluse LA; Martin BP; Gregory GP; Lefebure M; Vidacs E; Tothill RW; Bradner JE; Shortt J; Johnstone RW Mol Cancer Ther; 2016 Sep; 15(9):2030-41. PubMed ID: 27406984 [TBL] [Abstract][Full Text] [Related]
39. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis. Hartmann K; Artuc M; Baldus SE; Zirbes TK; Hermes B; Thiele J; Mekori YA; Henz BM Am J Pathol; 2003 Sep; 163(3):819-26. PubMed ID: 12937123 [TBL] [Abstract][Full Text] [Related]
40. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis. Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]